Back to News
Market Impact: 0.1
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
Source: globenewswire.com
Healthcare & BiotechMedia & Entertainment
NeOnc (NASDAQ: NTHI), a clinical-stage biotech focused on brain cancer, is bringing its story to Fox Business Network. The snippet cites unspecified developments drawing attention to the company but provides no clinical, financial, or market-performance details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
NTHI0.00
More News
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
- Moderna shares plunge after leak of partial cancer vaccine data
- Moderna's stock tumbles after reported leak of data for cancer vaccine
- Palmer Luckey teams with dire wolf billionaire Ben Lamm to launch $200 million Warhound, unleashing genetically engineered clone dogs of war
- Zai Lab raises $250 million in private placement financing
- Disney’s multiplatform Super Bowl plan frustrates ABC affiliates